Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation

Secondary cancers developing after allogeneic hematopoietic stem cell transplantation generally originate from recipient-derived cells. In this study, we analyzed the tumor cell origin of 5 epithelial malignant tumors (esophageal squamous cell carcinoma, lung adenocarcinoma, gastric adenocarcinoma,...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of surgical pathology Vol. 36; no. 9; p. 1376
Main Authors Munakata, Wataru, Nomoto, Junko, Takahashi, Noriko, Taniguchi, Hirokazu, Maeshima, Akiko Miyagi, Asamura, Hisao, Tanosaki, Ryuji, Heike, Yuji, Fukuda, Takahiro, Tobinai, Kensei, Kobayashi, Yukio
Format Journal Article
LanguageEnglish
Published United States 01.09.2012
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Secondary cancers developing after allogeneic hematopoietic stem cell transplantation generally originate from recipient-derived cells. In this study, we analyzed the tumor cell origin of 5 epithelial malignant tumors (esophageal squamous cell carcinoma, lung adenocarcinoma, gastric adenocarcinoma, pharyngeal squamous cell carcinoma, and thyroid papillary carcinoma) that developed after allogeneic peripheral blood stem cell transplantation using anti-AE1/3 immunofluorescence with fluorescence in situ hybridization analysis for sex chromosomes and/or short-tandem repeat microsatellite analysis of laser-microdissected tumor cells. The results revealed that 1 of these 5 cancers was derived from donor cells. In this case, transfused pluripotent cells, which include both mesenchymal stem cells and hematopoietic stem cells, might have given rise to epithelial malignant cells. Our observations suggest that transfused peripheral blood cells may be involved in the development of cancers after allogeneic peripheral blood stem cell transplantation.
ISSN:1532-0979
DOI:10.1097/pas.0b013e318261089c